Page 127 - GPD-3-4
P. 127

Gene & Protein in Disease                                       PIVKA-II in differential diagnosis of AFP-NHCC



            Ethics approval and consent to participate            doi: 10.3748/wjg.v23.i18.3228

            This study has been reviewed by the Ethics Review   9.   Nagel T, Klaus F, Ibanez IG, Wege H, Lohse A, Meyer B. Fast
            Committee (ethics number: 20240966). The research     and facile analysis of glycosylation and phosphorylation
            purpose, process, and significance have been explained to   of  fibrinogen  from  human  plasma-correlation  with
                                                                  liver cancer and liver cirrhosis.  Anal Bioanal Chem.
            the patients and their families, and all the included subjects   2018;410(30):7965-7977.
            have signed informed consent forms for participating in
            this clinical research.                               doi: 10.1007/s00216-018-1418-7
                                                               10.  Wang ZX, Jiang CP, Cao Y, Zhang G, Chen WB, Ding YT.
            Consent for publication                               Preoperative serum liver enzyme markers for predicting early
            Not applicable.                                       recurrence after curative resection of hepatocellular carcinoma.
                                                                  Hepatobiliary Pancreat Dis Int. 2015;14(2):178-185.
            Availability of data                                  doi: 10.1016/s1499-3872(15)60353-8
            Data are available from the corresponding author upon   11.  Zhang LX, Lv Y, Xu AM, Wang HZ. The prognostic
            reasonable request.                                   significance of serum gamma-glutamyltransferase levels
                                                                  and AST/ALT in primary hepatic carcinoma. BMC Cancer.
            References                                            2019;19(1):841.

            1.   Wen N, Cai Y, Li F,  et al. The clinical management of      doi: 10.1186/s12885-019-6011-8
               hepatocellular  carcinoma  worldwide:  A  concise  review
               and comparison of current guidelines: 2022 update. Biosci   12.  Sylman JL, Mitrugno A, Atallah M, et al. The predictive value
               Trends. 2022;16(1):20-30.                          of inflammation-related peripheral blood measurements in
                                                                  cancer staging and prognosis. Front Oncol. 2018;8:78.
               doi: 10.5582/bst.2022.01061
                                                                  doi: 10.3389/fonc.2018.00078
            2.   Zhang CH, Cheng Y, Zhang S, Fan J, Gao Q. Changing
               epidemiology of hepatocellular carcinoma in Asia. Liver Int.   13.  Kumar A, Jat KR, Sankar J, Lakshmy R, Lodha R, Kabra  SK.
               2022;42(9):2029-2041.                              Role of high-sensitivity C-reactive protein (hs-CRP)
                                                                  in assessment of asthma control in children.  J  Asthma.
               doi: 10.1111/liv.15251                             2023;60(7):1466-1473.
            3.   Wang W, Wei C. Advances in the early diagnosis of      doi: 10.1080/02770903.2022.2155187
               hepatocellular carcinoma. Genes Dis. 2020;7(3):308-319.
                                                               14.  Yin J, Wang L, Jin T,  et al. A  cell wall-localized NLR
               doi: 10.1016/j.gendis.2020.01.014                  confers resistance to Soybean mosaic virus by recognizing
            4.   Villanueva A. Hepatocellular Carcinoma.  N  Engl  J  Med.   viral-encoded cylindrical inclusion protein.  Mol Plant.
               2019;380(15):1450-1462.                            2021;14(11):1881-1900.
               doi: 10.1056/NEJMra1713263                         doi: 10.1016/j.molp.2021.07.013
            5.   Mao M, Wang X, Song Y,  et al. Novel prognostic scores   15.  Payancé A, Dioguardi Burgio M, Peoc’h K, et al. Biological
               based on plasma prothrombin time and fibrinogen levels   response under treatment and prognostic value of protein
               in patients with AFP-negative hepatocellular carcinoma.   induced by vitamin K absence or antagonist-II in a French
               Cancer Control. 2020;27(1):1073274820915520.       cohort of patients with hepatocellular carcinoma.  Eur  J
                                                                  Gastroenterol Hepatol. 2020;32(10):1364-1372.
               doi: 10.1177/1073274820915520
                                                                  doi: 10.1097/meg.0000000000001652
            6.   Li J, Wang Q, Yan Y, et al. Development and validation of
               a prognostic nomogram to predict the recurrence of AFP-  16.  Proctor MJ, Morrison DS, Talwar D,  et al. A  comparison
               negative and DCP-positive hepatocellular carcinoma after   of inflammation-based prognostic scores in patients with
               curative resection. Front Oncol. 2024;14:1414083.  cancer. A  glasgow inflammation outcome study.  Eur J
                                                                  Cancer. 2011;47(17):2633-2641.
               doi: 10.3389/fonc.2024.1414083
                                                                  doi: 10.1016/j.ejca.2011.03.028
            7.   Tzartzeva K, Obi J, Rich NE,  et al. Surveillance imaging
               and alpha fetoprotein for early detection of hepatocellular   17.  Najjar M, Agrawal S, Emond JC, Halazun KJ. Pretreatment
               carcinoma in patients with cirrhosis: A  meta-analysis.   neutrophil-lymphocyte ratio: useful prognostic biomarker
               Gastroenterology. 2018;154(6):1706-1718.e1.        in hepatocellular carcinoma.  J  Hepatocell Carcinoma.
                                                                  2018;5:17-28.
               doi: 10.1053/j.gastro.2018.01.064
                                                                  doi: 10.2147/jhc.S86792
            8.   Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and
               regeneration. World Gastroenterol. 2017;23(18):3228-3239.  18.  Zenga J, Awan MJ, Frei A, et al. Chronic stress promotes


            Volume 3 Issue 4 (2024)                         8                               doi: 10.36922/gpd.4269
   122   123   124   125   126   127   128   129   130   131   132